We therefore determined the activity of a β-catenin/TCF-dependent promoter in proliferating normal uroepithelial cells and seven TCC cell lines, using a hepatoma line with oncogenic β-catenin as a control. Here, HNF4A is linked to hepatocellular carcinoma.